Atlas Trials

BRAF V600E

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch BRAF V600E

RecordFirmDate
A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer. (NCT05004350)Pierre Fabre Medicament2021-09-14
ENCOrafenib With Binimetinib in bRAF NSCLC (NCT04526782)Intergroupe Francophone de Cancerologie Thoracique2021-01-19
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib. (NCT04534283)Anita Turk2020-10-05
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG (NCT03973918)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2019-07-29
Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation (NCT03543306)Asan Medical Center2018-06-30
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas (NCT03593993)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2018-05-19
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy (NCT03042221)University of Colorado, Denver2016-05-10

Track BRAF V600E automatically

Every clearance here is in the API, with alerts when new ones post.